BridgeMD
New treatment option for Excessive Daytime Sleepiness
Official title A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
ClinicalTrials.gov ID: NCT07082829
What this study is testing
What is ORX142 Tablets?
ORX142 Tablets is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for excessive daytime sleepiness.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Healthy males or females as determined by assessments at the Screening Visit. For Parts A, B, C, and E: a. Participants must be at least 18 years of...
- For Part D: a .Participants must be at least 60 years of age and no more than 80 years of age at the Screening Key
You likely can't join if
- Presence of significant cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, malignancy, endocrine, neurological, or psychiatric...
- History of seizure disorder, any other condition that increases the risk of seizure
- Has a clinically significant sleep disorder, including insomnia or sleep apnea.
The study team makes the final eligibility decision.
Where it's taking place
- Lincoln, Nebraska, United States
- Eatontown, New Jersey, United States
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lincoln, Nebraska, United States; Eatontown, New Jersey, United States; New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.